Tower Research Capital LLC (Trc) Brainstorm Cell Therapeutics Inc. Transaction History

Tower Research Capital LLC (Trc)

  • $4.07 Billion
  • Q1 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Brainstorm Cell Therapeutics Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 11,005 shares of BCLI stock, worth $3,741. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,005
Previous 18,236 39.65%
Holding current value
$3,741
Previous $4,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.28 - $0.66 $2,024 - $4,772
-7,231 Reduced 39.65%
11,005 $6,000
Q4 2023

Feb 13, 2024
SELL
$0.15 - $0.4 $3,119 - $8,318
-20,795 Reduced 53.28%
18,236 $4,000
Q3 2023

Nov 14, 2023
BUY
$0.2 - $2.08 $6,432 - $66,896
32,162 Added 468.22%
39,031 $7,000
Q2 2023

Aug 14, 2023
SELL
$2.0 - $3.2 $3,986 - $6,377
-1,993 Reduced 22.49%
6,869 $14,000
Q1 2023

May 09, 2023
BUY
$1.43 - $3.3 $11,162 - $25,759
7,806 Added 739.2%
8,862 $29,000
Q4 2022

Feb 10, 2023
BUY
$1.37 - $3.39 $1,446 - $3,579
1,056 New
1,056 $2,000
Q2 2022

Aug 15, 2022
BUY
$2.71 - $3.6 $15,024 - $19,958
5,544 New
5,544 $15,000
Q1 2022

May 12, 2022
SELL
$2.92 - $4.19 $10,050 - $14,421
-3,442 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$2.81 - $4.23 $9,672 - $14,559
3,442 New
3,442 $14,000
Q2 2021

Aug 16, 2021
SELL
$3.01 - $4.01 $35,533 - $47,338
-11,805 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$3.46 - $7.88 $25,821 - $58,808
7,463 Added 171.88%
11,805 $45,000
Q4 2020

Feb 16, 2021
SELL
$3.99 - $17.73 $76,967 - $342,011
-19,290 Reduced 81.63%
4,342 $20,000
Q3 2020

Nov 16, 2020
BUY
$11.19 - $16.92 $249,660 - $377,502
22,311 Added 1688.95%
23,632 $400,000
Q2 2020

Aug 13, 2020
SELL
$4.42 - $12.66 $45,826 - $131,258
-10,368 Reduced 88.7%
1,321 $15,000
Q1 2020

May 15, 2020
BUY
$4.01 - $8.88 $2,141 - $4,741
534 Added 4.79%
11,689 $54,000
Q4 2019

Feb 07, 2020
BUY
$3.62 - $4.29 $38,060 - $45,105
10,514 Added 1640.25%
11,155 $48,000
Q3 2019

Nov 05, 2019
BUY
$3.54 - $4.48 $2,269 - $2,871
641 New
641 $2,000
Q4 2018

Feb 14, 2019
SELL
$2.98 - $3.9 $2,050 - $2,683
-688 Closed
0 $0
Q3 2018

Nov 13, 2018
SELL
$3.73 - $4.38 $2,607 - $3,061
-699 Reduced 50.4%
688 $3,000
Q2 2018

Aug 15, 2018
BUY
$3.12 - $5.19 $539 - $897
173 Added 14.25%
1,387 $5,000
Q1 2018

May 15, 2018
SELL
$3.01 - $3.77 $872 - $1,093
-290 Reduced 19.28%
1,214 $4,000
Q4 2017

Feb 09, 2018
SELL
$2.96 - $4.42 $849 - $1,268
-287 Reduced 16.02%
1,504 $6,000
Q3 2017

Nov 14, 2017
BUY
$3.98 - $4.36 $7,128 - $7,808
1,791
1,791 $7,000

Others Institutions Holding BCLI

# of Institutions
52
Shares Held
4.09M
Call Options Held
63.2K
Put Options Held
800
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $12.4M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email